Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Takeda Pharmaceutical Co., Ltd. (TKPHF)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
25.040 -0.730    -2.83%
14:30:00 - Delayed Data. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 100
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 25.040 - 25.040
Takeda Pharmaceutical 25.040 -0.730 -2.83%

TKPHF Cash Flow Statement

 
Featured here, the Cash Flow Statement for Takeda Pharmaceutical Co., Ltd., showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Cash Flow Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Period Length: 0 Months 0 Months 0 Months 0 Months
Net Income/Starting Line 105720 -48030 89395 31134
Cash From Operating Activities 146451 198905 92400 293693
Depreciation/Depletion 68765 42719 42078 59554
Amortization 118296 139977 129423 76295
Deferred Taxes - - - -
Non-Cash Items 19692 -4991 50091 -42243
Cash Receipts - - - -
Cash Payments - - - -
Cash Taxes Paid 47379 66349 52580 20900
Cash Interest Paid 28974 29896 19815 21992
Changes in Working Capital -166022 69230 -218587 143392
Cash From Investing Activities -75269 -60579 -266530 -438492
Capital Expenditures -47080 -37847 -45957 -35769
Other Investing Cash Flow Items, Total -28189 -22732 -220573 -402723
Cash From Financing Activities -97760 -140655 -57778 -6600
Financing Cash Flow Items -33002 25480 -24072 -25205
Total Cash Dividends Paid -138251 -9065 -130746 -10419
Issuance (Retirement) of Stock, Net - - -2326 -
Issuance (Retirement) of Debt, Net 73493 -157070 99366 29024
Foreign Exchange Effects - - - -9729
Net Change in Cash -29692 1671 -217150 -151611
Beginning Cash Balance 318051 316380 533530 685141
Ending Cash Balance 288359 318051 316380 533530
Free Cash Flow -41669 65067.5 -298325.38 78533.25
Free Cash Flow Growth -164.04 121.81 -479.87 -68.11
Free Cash Flow Yield 1.09 1.77 -2.51 -2.22
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the cash flow statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4502 Comments

Write your thoughts about Takeda Pharmaceutical Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email